0001209191-17-029191.txt : 20170502 0001209191-17-029191.hdr.sgml : 20170502 20170502162027 ACCESSION NUMBER: 0001209191-17-029191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170501 FILED AS OF DATE: 20170502 DATE AS OF CHANGE: 20170502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Masoudi Gerald CENTRAL INDEX KEY: 0001641287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 17805296 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE STREET 2: C/O CELGENE CORP CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-01 0 0000816284 CELGENE CORP /DE/ CELG 0001641287 Masoudi Gerald C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 Executive Vice President Stock Option (right to buy) 124.06 2017-05-01 4 A 0 10245 0.00 A 2027-05-01 Common Stock 10245 10245 D Restricted Stock Unit 2017-05-01 4 A 0 5180 0.00 A Common Stock 5180 5180 D Option is immediately exercisable and will vest in four equal annual installments commencing on May 1, 2018. The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) and will vest on May 1, 2020. Vested shares will be delivered to the reporting person on the vesting date. Executive Vice President, General Counsel and Corporate Secretary /s/ Peter N. Kellogg, Executive Vice President and Chief Financial Officer 2017-05-01